Novel Gilvocarcin-Type Natural Products Against Luncg Cancer by Combinatorial Biosynthesis

Grants and Contracts Details

StatusFinished
Effective start/end date2/1/041/31/08

Funding

  • KY Lung Cancer Research Fund: $282,016.00